Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/24/1995US5461044 Cephalosporin derivatives
10/24/1995US5461043 Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate
10/24/1995US5461042 Regulation of the immune system
10/24/1995US5461041 Progestogen-only contraceptive
10/24/1995US5461039 Method for treating hypertension employing a cholesterol lowering drug
10/24/1995US5461037 Preventing hyperlipidemia by intravenously infusing a mixture of low dosage phosphates and glyceride oil
10/24/1995US5461036 Treating colon, gastric, esophageal cancer
10/24/1995US5461031 Monomeric insulin analog formulations
10/24/1995US5461030 Compositions and methods for enhancing wound healing
10/24/1995US5460972 Using ion selective electrodes; diagnosis, prognosis
10/24/1995US5460829 Fine particle size
10/24/1995US5460826 Morphine therapy
10/24/1995US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women
10/24/1995US5460819 Method for treating PQQ-responsive heavy metal toxicity
10/24/1995US5460813 Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin
10/24/1995US5460807 Polyurea or polyamide oligomers useful for inhibiting smooth muscle cells
10/24/1995US5460605 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
10/24/1995CA2017265C Cosmetic composition against ageing of the skin
10/24/1995CA2015585C Method and compositions for treatment of mast cell-mediated dermatologic disorders
10/24/1995CA2006404C Transdermal therapeutical system comprising physostigmine as component and process for the production thereof
10/24/1995CA1337432C Method of lowering the blood pressure
10/24/1995CA1337429C Derivatives of 2,2'-iminobisethanol
10/24/1995CA1337425C Substituted (n-ethylamino)methyl-1,2,3,4- tetrahydronaphthalene compounds having alpha-2 adrenergic antagonist activity
10/24/1995CA1337424C Antitumour compounds from marine sponge of the genus dercitus
10/24/1995CA1337421C 1-indolylalkyl-4-(substituted-pyridinyl)piperazines
10/24/1995CA1337420C (substituted aralkyl) heterocyclic compounds
10/24/1995CA1337418C 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
10/24/1995CA1337417C Pyridyl- and pyrimidyl derivatives
10/24/1995CA1337415C Indole derivatives
10/24/1995CA1337408C Soluble phosphorylated glucan
10/24/1995CA1337403C Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
10/24/1995CA1337401C Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/24/1995CA1337399C Ibuprofen taste-masking process
10/24/1995CA1337396C Compositions and in situ methods for forming films on body tissue
10/23/1995CA2146607A1 Pharmaceutical composition for treatment of epidermis profilerative disease
10/23/1995CA2121952A1 Topical preparations for the treatment of acne and acneiform dermatitis
10/22/1995CA2147419A1 Pharmaceutical composition for treating osteoporosis
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/21/1995CA2147343A1 Process for the purification of perfluoroalkyl bromides or perfluoroalkylene dibromides
10/21/1995CA2146038A1 Method for preparing homochiral maleimide intermediates, via silylation techniques, used in the enantioselective preparation of anti-thrombotic and anti-vasospastic compounds
10/21/1995CA2121737A1 An antihypoxic formulation
10/19/1995WO1995027724A1 An equilin double bond isomer from the acid isomerization of equilin
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027720A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs
10/19/1995WO1995027714A1 Active compounds
10/19/1995WO1995027713A1 Process for the resolution of etodolac using glucamine derivatives
10/19/1995WO1995027712A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027704A1 Anti-helicobacter ester and carbamate derivatives of azolones
10/19/1995WO1995027699A1 Aminostilbazole derivative and medicine
10/19/1995WO1995027697A1 22-thiavitamin d3 derivative
10/19/1995WO1995027519A1 Antiviral compounds, compositions and uses thereof
10/19/1995WO1995027511A1 NEW COMBINATION OF A β-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC
10/19/1995WO1995027510A1 Screening methods for integumental inflammation modulating agents
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027492A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995WO1995027491A1 Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995027489A1 Composition for treating neurological disorders
10/19/1995WO1995027488A1 Solid vitamin c preparation and a method of producing the same
10/19/1995WO1995027486A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
10/19/1995WO1995027485A1 Methods of using iron chelating compounds to reduce free radical damage in mammals
10/19/1995WO1995027484A1 Method of regulating dysfunctional dopaminergic and cholinergic activity and related diseases
10/19/1995WO1995027483A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995027471A1 Improved anti-dandruff shampoo
10/19/1995DE4413839C1 Prepn. to protect human bodies from oxidative processes
10/19/1995DE4412613A1 Medical and veterinary use of synthetic humate prods.
10/19/1995CA2187651A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
10/19/1995CA2187536A1 Method of treating allergic rhinitis
10/19/1995CA2187367A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2187185A1 Halofantrine free base for the treatment of malaria and compositions
10/19/1995CA2186486A1 An equilin double bond isomer from the acid isomerization of equilin
10/19/1995CA2185552A1 Anti-helicobacter ester and carbamate derivatives of azolones
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/18/1995EP0677530A1 Process for the preparation of azithromycin dihydrochloride
10/18/1995EP0677524A1 Thieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives as PAF antagonists
10/18/1995EP0677523A1 3-(substituted)-1-carba(dethia)-3-cephems and cephalosporins and a process for production therefor
10/18/1995EP0677519A1 Chroman derivative and medicinal use thereof
10/18/1995EP0677517A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D
10/18/1995EP0677516A1 Cyclic amide derivatives
10/18/1995EP0677514A1 New cyclopropyl derivatives, preparation method thereof and applications
10/18/1995EP0677292A1 Anti-viral and anti-cancer agents
10/18/1995EP0677291A2 Composition and method containing optically pure (S) metoprolol
10/18/1995EP0677290A1 Percutaneous preparation comprising tulobuterol
10/18/1995EP0677289A2 Pharmaceutical composition for treating osteoporosis
10/18/1995EP0677288A1 Cosmetic or pharmaceutic composition comprising an alkyl-carbonate as moisturizing agent
10/18/1995EP0677171A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
10/18/1995EP0677126A1 Antiviral topical pharmaceutical compositions
10/18/1995EP0677103A1 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677054A1 New antiparasitic agents related to the milbemycins and avermectins
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/18/1995EP0677050A1 Novel pyridone carboxylic acid derivatives
10/18/1995EP0677049A1 Quinazoline derivatives
10/18/1995EP0677043A1 Platelet aggregation inhibiting compounds
10/18/1995EP0677042A1 Selective ligands of receptors 5-ht 1d?-5ht 1b? derived from indole-piperazine useful as medicaments
10/18/1995EP0677041A1 Chemical compounds
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
1 ... 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 ... 7860